Mathew Stephens
Vendite & Marketing presso Endomagnetics Ltd.
Profilo
Mathew Stephens is currently working as the Commercial Director at Endomagnetics Ltd.
He started this position in 2016.
Prior to his current role, he worked as the Principal at S.R.A.
Developments Ltd.
Mathew completed his undergraduate degree at the University of Bath.
Posizioni attive di Mathew Stephens
| Società | Posizione | Inizio |
|---|---|---|
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Vendite & Marketing | 01/08/2013 |
Precedenti posizioni note di Mathew Stephens
| Società | Posizione | Fine |
|---|---|---|
S.R.A. Developments Ltd.
 S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Corporate Officer/Principal | - |
Formazione di Mathew Stephens
| University of Bath | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
S.R.A. Developments Ltd.
S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- Mathew Stephens
